Crossmark

Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies

Crossref DOI link: https://doi.org/10.1136/jitc-2021-003024

Published Online: 2022-01-25

Published Print: 2022-01

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Michielin, Olivier

Lalani, Aly-Khan

Robert, Caroline

Sharma, Padmanee

Peters, Solange
Funding

Funding for this research was provided by:

Bristol-Myers Squibb
License Information

License valid from 2022-01-24